Les Drs Andrea Britton, Helen Byrnes, et Thinlay Bhutia commentent un article paru dans un récent numéro de Rage Info qui décrivait l’intervention contre la rage au Tamil Nadu et la modélisation du coût-bénéfice réalisée par Fitzpatrick et al. et parue dans la revue PNAS de décembre 2016.
An 11-day on-site course organized by the Pasteur Institute of Iran with the support of many partners including the World Health Organization (WHO) and the PREDEMICS consortium. It is planned for October 8th to 19th 2017 at the Pasteur Institut of Iran.
To share what inspires those involved in the effort to eradicate rabies, we are taking a closer look at the work and the lives of some of the winners of the World Rabies Day MSD Animal Health Award from 2016.
A round-up of recent research articles in line with GARC's mission
Dozens of potential exposures to rabies were reported in Peru's Cusco region, but of the 85 suspected of having contact with rabid bats, only three clinical cases have been confirmed at the time of this report. Of these three cases, two victims still survive.
February is National Spay/Neuter Awareness Month in the US, and February 28th is World Spay Day this year.
Tamil Nadu, a state in Southern India with a population of 77.9 million people, could improve upon its current rabies control strategy and reduce its human rabies deaths by 90% if it embraced the One Health concept that links the health of animals to the heath of humans more fully.
The annual Rabies in the Americas (RITA) conference was held on October 23-28th in Belem, Brazil in the heart (and the heat!) of the Amazon region and brought together veterinarians, public health officials, academics and students to present and discuss the latest research on rabies and how to control and prevent its spread in domestic animals and wildlife in the Americas.
A recent article by Mani et al. discusses a new trend in India: within the last 6 years there have been six survivors of clinical rabies contracted from dogs. The authors attribute this upward trend in survival to increased access to conventional critical care facilities and more doctors trying to save rabies patients.
In 2015–16, a collaborative project between WSU and MSD Animal Health began investigating whether the commonly-used canine rabies vaccine Nobivac® Rabies had thermotolerant properties. The first phase of this trial, which investigated the effect that various levels of non cold-chain storage had on the potency of the vaccine, indicated that this vaccine retained its efficacy following storage at 25°C for six months and 30°C for three months.
